Search research articles
Contact Us
Filters
Showing results (111-120 of 135) with videos related to
Page
of 14
Sort By:
Open Forum Infectious Diseases
|
September 23, 2022
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus
Bernadette Jakeman, Alexandra U Scherrer, Katharine E A Darling, et al.
Plos One
|
March 2, 2021
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland
Katharine E A Darling, Isabella Locatelli, Nadia Benghalem, et al.
British Journal of Haematology
|
November 16, 2022
Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation
Andriyana K Bankova, Chloé Pasin, Alice Huang, et al.
Transplantation and Cellular Therapy
|
January 29, 2022
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation
Alice Huang, Caroline Cicin-Sain, Chloe Pasin, et al.
The Journal of Infectious Diseases
|
December 15, 2021
Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years
Isabella C Schoepf, Christian W Thorball, Bruno Ledergerber, et al.
AIDS (London, England)
|
July 25, 2022
Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV
Frédérique Chammartin, Katharina Kusejko, Chloé Pasin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 2, 2022
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial
Benjamin Speich, Frédérique Chammartin, Irene A Abela, et al.
BMJ Open
|
April 20, 2026
Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trial
Natalie Rose, Nadine S Bernasconi, Michaela Schumacher, et al.
Thrombosis Research
|
November 17, 2022
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial
Davide Voci, Andrea Götschi, Ulrike Held, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Fsr quorum sensing system restricts biofilm growth and activates inflammation in enterococcal infective endocarditis
Haris Antypas, Verena Schmidtchen, Willy Isao Staiger, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 135) with videos related to
Sort By:
Page
of 14
Open Forum Infectious Diseases
|
September 23, 2022
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus
Bernadette Jakeman, Alexandra U Scherrer, Katharine E A Darling, et al.
Plos One
|
March 2, 2021
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland
Katharine E A Darling, Isabella Locatelli, Nadia Benghalem, et al.
British Journal of Haematology
|
November 16, 2022
Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation
Andriyana K Bankova, Chloé Pasin, Alice Huang, et al.
Transplantation and Cellular Therapy
|
January 29, 2022
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation
Alice Huang, Caroline Cicin-Sain, Chloe Pasin, et al.
The Journal of Infectious Diseases
|
December 15, 2021
Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years
Isabella C Schoepf, Christian W Thorball, Bruno Ledergerber, et al.
AIDS (London, England)
|
July 25, 2022
Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV
Frédérique Chammartin, Katharina Kusejko, Chloé Pasin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 2, 2022
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial
Benjamin Speich, Frédérique Chammartin, Irene A Abela, et al.
BMJ Open
|
April 20, 2026
Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trial
Natalie Rose, Nadine S Bernasconi, Michaela Schumacher, et al.
Thrombosis Research
|
November 17, 2022
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial
Davide Voci, Andrea Götschi, Ulrike Held, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Fsr quorum sensing system restricts biofilm growth and activates inflammation in enterococcal infective endocarditis
Haris Antypas, Verena Schmidtchen, Willy Isao Staiger, et al.
Page
of 14